ATHAGORAS Group acquires CSO Pharma Consulting to enhance its consulting services in the pharmaceutical industry, combining expertise to drive innovation and growth.

Target Company Overview

CSO Pharma Consulting GmbH, based in Munich, Germany, specializes in providing consulting services within the pharmaceutical and healthcare sectors. The company excels in the areas of pharmacovigilance, medical affairs, quality management, and Good Distribution Practice (GDP) consulting. This acquisition by ATHAGORAS Group positions CSO to enhance its service offerings and leverage ATHAGORAS’ industry presence to drive further innovation and growth.

As a trusted partner for pharmaceutical companies and healthcare providers, CSO Pharma Consulting offers an audited pharmacovigilance system and tailored consulting solutions. Their emphasis on individual consulting paired with robust operational support enables them to meet diverse client needs effectively, thereby maintaining high levels of customer satisfaction.

Industry Overview in Germany

The pharmaceutical and healthcare consulting industry in Germany is experiencing rapid growth, fueled by increasing regulatory demands and heightened focus on patient safety.

View Source

Similar Deals

Wellhub Urban Sports Club

2025

Strategic Partnership Healthcare Facilities & Services (NEC) Germany
Teleflex Incorporated Vascular Intervention division of BIOTRONIK

2025

Strategic Partnership Medical Devices & Implants Germany
Bristol Myers Squibb Evotec SE

2025

Strategic Partnership Proprietary & Advanced Pharmaceuticals Germany
ZEISS Vision Care Ocumeda

2025

Strategic Partnership Telemedicine Services Germany
Bioventure Management GmbH Repairon GmbH

2025

Strategic Partnership Bio Medical Devices Germany
Viessmann Generations Group schülke

2024

Strategic Partnership Healthcare Facilities & Services (NEC) Germany

ATHAGORAS Group

invested in

CSO Pharma Consulting

in 2024

in a Strategic Partnership deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert